Atriobiventricular pacing improves exercise capacity in patients with heart failure and intraventricular conduction delay.

Abstract Objectives We sought to assess the efficacy of biventricular pacing with respect to both peak and submaximal measures of exercise in patients with New York Heart Association class III heart failure (HF) and intraventricular conduction delay in a randomized, blinded study. Background Submaximal and maximal changes in exercise capacity need evaluating in this patient population with this novel therapy. Methods Graded exercise and 6-min walk tests were performed in patients randomized to three months each of active (atrio-biventricular) and inactive pacing. Minute ventilation (VE), oxygen uptake (VO 2 ), ventilated carbon dioxide (VCO 2 ) and heart rate were measured in patients achieving a respiratory quotient >1 (n = 30). Oxygen pulse, anaerobic threshold (AT) and ventilatory efficiency (VE/VCO 2 ) were calculated. Results Active biventricular pacing increased peak VO 2 (15.8 ± 4.3 vs. 14.4 ± 4.6 ml/kg/min, p = 0.02), exercise time (501 ± 223 s vs. 437 ± 233 s, p 2 slope in 59% of patients (chi-square test, p = 0.002) with active pacing. Conclusions Biventricular pacing may improve maximal and submaximal exercise capacity in patients with advanced HF and intraventricular conduction delay.